This trial will compare outcomes of patients discharged the day of surgery versus the day after for those undergoing mastectomy with immediate implant-based breast reconstruction.
6 Primary · 6 Secondary · Reporting Duration: Up to 30 Days
Active Control
Experimental Treatment
100 Total Participants · 2 Treatment Groups
Primary Treatment: Discharge timing · No Placebo Group · N/A
Age 19 - 80 · Female Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: